Innovation
Prevention is the best medicine
We get ahead of disease together by preventing and treating it with innovation in vaccines and specialty medicines.
Investors
We announced our quarter 3 2025 results on Wednesday, October 29th.
Press releases
- GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
- Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
- Blujepa (gepotidacin) approved by US FDA as oral option for treatment of uncomplicated urogenital gonorrhea (uGC)

GSK Global links
Visit our Global site for additional features








